Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.GlobeNewsWire • Thursday
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Grifols, S.A. and Encourages Investors with Losses to Contact the FirmAccesswire • Wednesday
Spanish drug maker Grifols will bring in independent directors, chairman tells newspaperReuters • 04/14/24
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Grifols, S.A. and Encourages Investors with Losses to Contact the FirmAccesswire • 04/08/24
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus ScreeningGlobeNewsWire • 04/04/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - GRFSPRNewsWire • 03/27/24
Gotham City issues new report on Grifols, maintains questions over accounting practicesReuters • 02/20/24
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Grifols, S.A. and Encourages Investors with Losses to Contact the FirmAccesswire • 02/13/24
ROSEN, TOP RANKED NATIONAL INVESTOR ATTORNEYS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLFPRNewsWire • 01/27/24
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Grifols, S.A. and Encourages Investors with Losses to Contact the FirmAccesswire • 01/25/24
Grifols to respond "very, very soon", before deadline, to supervisor request - board memberReuters • 01/19/24